piracetam has been researched along with Anoxemia in 57 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levetiracetam is an anti-epileptic drug commonly used in intensive care when seizure is suspected as a possible cause of coma." | 7.85 | Marked EEG worsening following Levetiracetam overdose: How a pharmacological issue can confound coma prognosis. ( André-Obadia, N; Bouchier, B; Demarquay, G; Gobert, F; Guérin, C, 2017) |
| " This study investigates a potential additive neuroprotective effect of levetiracetam combined with hypothermia after hypoxia-induced brain injury in neonatal mice." | 7.83 | Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain. ( Bendix, I; Bertsche, A; Fandrey, J; Felderhoff-Mueser, U; Hoeber, D; Kluever, V; Lueckemann, L; Strasser, K; Thavaneetharajah, S, 2016) |
| "The present study investigates the potential of Piracetam and Vinpocetine (nootropic drugs, known to possess neuroprotective properties) in preventing hypoxia-reoxygenation induced oxidative stress in primary hippocampal cell culture." | 7.77 | Preventive effect of piracetam and vinpocetine on hypoxia-reoxygenation induced injury in primary hippocampal culture. ( Ilavzhagan, G; Muthuraju, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P, 2011) |
| " The elimination half-life was 4." | 6.68 | Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man. ( Anderer, P; Grünberger, J; Hitzenberger, G; Linzmayer, L; Rameis, H; Saletu, B; Zyhlarz, G, 1995) |
| "Piracetam and inosine treatment was associated with the inhibition of free-radical lipid oxidation and a reduction of hypoxia, those being accompanied by increased collagenogenesis and accelerated postinfarction scar formation." | 6.66 | [Stimulation of reparative processes in myocardial infarction: comparative evaluation of the effects of piracetam and inosine]. ( Berestov, AA; Golikov, AP; Karev, VA; Konorev, LA; Polumiskov, VIu, 1988) |
| "The effects of two acute doses (1600 mg, 2400 mg) of 2-oxo-pyrrolidine-1-acetamide (piracetam, Normabraïn) on hypoxia resistance were screened vs placebo in a randomized, double-blind 3-way change-over design in 9 healthy male volunteers (mean age: 26." | 5.06 | Randomized placebo-controlled double-blind cross-over study on antihypoxidotic effects of piracetam using psychophysiological measures in healthy volunteers. ( Klausnitzer, W; Schaffler, K, 1988) |
| "Levetiracetam is an anti-epileptic drug commonly used in intensive care when seizure is suspected as a possible cause of coma." | 3.85 | Marked EEG worsening following Levetiracetam overdose: How a pharmacological issue can confound coma prognosis. ( André-Obadia, N; Bouchier, B; Demarquay, G; Gobert, F; Guérin, C, 2017) |
| " This study investigates a potential additive neuroprotective effect of levetiracetam combined with hypothermia after hypoxia-induced brain injury in neonatal mice." | 3.83 | Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain. ( Bendix, I; Bertsche, A; Fandrey, J; Felderhoff-Mueser, U; Hoeber, D; Kluever, V; Lueckemann, L; Strasser, K; Thavaneetharajah, S, 2016) |
| "The present study investigates the potential of Piracetam and Vinpocetine (nootropic drugs, known to possess neuroprotective properties) in preventing hypoxia-reoxygenation induced oxidative stress in primary hippocampal cell culture." | 3.77 | Preventive effect of piracetam and vinpocetine on hypoxia-reoxygenation induced injury in primary hippocampal culture. ( Ilavzhagan, G; Muthuraju, S; Prasad, D; Sharma, AK; Singh, SB; Solanki, P, 2011) |
| "In simulating acute hypoxic hypoxia with the participation of male volunteers, the authors investigated the antihypoxic and antioxidative activity of metabolic drugs (jakton, amtizole succinate, nootropil, probucol, and a mixture which consists of jakton, amtizole succinate, and probucol)." | 3.69 | [Pharmacological correction of lipid peroxidation during hypoxia and possibility to enhance human resistance to high altitude by using preparations of the metabolic type of action]. ( Bobrovnitskiĭ, IP; Cherniakov, IN; Nagornev, SN; Shishov, AA; Sytnik, SI, 1996) |
| " The antidepressants pyrazidol, azaphen, imipramine and moclobemide as well as the nootropic drug piracetam prolonged the life of animals in conditions of hypoxic and hemic hypoxia and increased the survival rate of rats in circulatory hypoxia." | 3.68 | [Effects of antidepressive agents on tolerance of hypoxia and physical exercise]. ( Andreeva, NI; Golovina, SM; Mashkovskiĭ, MD; Parshin, VA, 1991) |
| "The anti-hypoxic effect of piracetam was studied using the following experimental methods: hypobaric and anoxic hypoxia in mice, complete ischemia by decapitation in mice, incomplete ischemia by bilateral carotid occlusion in rats and hemic hypoxia in rats." | 3.67 | Anti-hypoxic effect of piracetam and its interaction with prostacyclin. ( Milanova, D; Nikolov, R; Nikolova, M, 1984) |
| " Cetyl GABA, sodium and lithium hydroxybutyrates and phenibut were shown to be able to decrease the retrograde amnesia caused by electroshock in passive avoidance performance." | 3.67 | [Nootropic properties of gamma-aminobutyric acid derivatives]. ( Ostrovskaia, RU; Trofimov, SS, 1984) |
| "The protective efficacy of pentoxiphylline, piracetam, and dihydroergotoxine against abrupt hypoxia was tested in a model of acute reversible respiratory failure, where repeated apnoeic attacks were induced by inhalation in repeated hypoxic exposures was reduced in control as well as in dihydroergotoxine-treated animals, it was increased after pentoxiphylline, and was not changed after piracetam." | 3.67 | Anti-hypoxic potency of cerebroprotective drugs studied in a model of acute reversible respiratory failure. ( Nistiarová, A; Tkácová, R; Tomori, Z, 1989) |
| "The effect of Piracetam on hypoxia-induced alterations of cerebral cortex electrogenesis is studied." | 3.67 | Effect of Piracetam on electrocorticogram and local cerebral glucose utilization in the rat. ( Balasch, J; Grau, M; Montero, JL, 1987) |
| "Piracetam (PIR) and dimethylaminoethanol (DMAE) were tested with respect to their ability to prevent changes of the locomotor behaviour and of the dopamine release from striatum slices after an intermittent postnatal hypoxia in the rat (2nd-10th day of postnatal life)." | 3.67 | Effects of nootropic drugs on some behavioural and biochemical changes after early postnatal hypoxia in the rat. ( Fischer, HD; Gramatté, T; Schmidt, J; Wustmann, C, 1986) |
| "The antihypoxic activity of Tisochromide (3-[4'-dimethylamino-4'-methylpentyl(2')-carbamoyl]-6,7-dimethoxy-1-thiaisochroman-1,1-dioxide), a substance of clinically antidepressant action, is studied on three hypoxia models and compared with that of the nootropic agent Piracetam: -- Tisochromide produces a dosis-dependent prolongation of the survival time of mice exposed to nitrogen hypoxia." | 3.66 | [Antihypoxic effect of tisochromide (16-244) in comparison with piracetam]. ( Hoffmann, W; Molodawkin, GM; Ostrovskaya, RU; Rostock, A, 1983) |
| " The elimination half-life was 4." | 2.68 | Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man. ( Anderer, P; Grünberger, J; Hitzenberger, G; Linzmayer, L; Rameis, H; Saletu, B; Zyhlarz, G, 1995) |
| "Piracetam and inosine treatment was associated with the inhibition of free-radical lipid oxidation and a reduction of hypoxia, those being accompanied by increased collagenogenesis and accelerated postinfarction scar formation." | 2.66 | [Stimulation of reparative processes in myocardial infarction: comparative evaluation of the effects of piracetam and inosine]. ( Berestov, AA; Golikov, AP; Karev, VA; Konorev, LA; Polumiskov, VIu, 1988) |
| "Piracetam was administered in doses of 4." | 2.65 | The effect of piracetam on volunteers in a low-pressure tank. ( Bande, J; Demay, F, 1980) |
| "Postanoxic myoclonus is a rare manifestation after an anoxic event, with fewer than 150 cases reported in the literature." | 1.40 | Postanoxic myoclonus: two case presentations and review of medical management. ( Budhram, A; Harvey, D; Lipson, D; Nesathurai, S; Rathbone, MP, 2014) |
| "Chronic post-anoxic myoclonus, also known as Lance-Adams syndrome, may develop following hypoxic brain injury, and is resistant to pharmacological therapy." | 1.40 | Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report. ( Božić, K; Divjak, I; Gebauer-Bukurov, K; Ješić, A; Sakalaš, L, 2014) |
| "The anti-seizure activity of both compounds occurred 30 min following intraperitoneal (i." | 1.34 | Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus. ( Tai, KK; Truong, DD, 2007) |
| "Asphyxic anoxia and hypoventilation hypoxia were used as models of general depression." | 1.27 | Effect of piracetam in some models of general and local depression of the cortical bioelectrical activity in cats. ( Dimov, S; Moyanova, S; Nikolov, R; Nikolova, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (57.89) | 18.7374 |
| 1990's | 7 (12.28) | 18.2507 |
| 2000's | 10 (17.54) | 29.6817 |
| 2010's | 7 (12.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budhram, A | 1 |
| Lipson, D | 1 |
| Nesathurai, S | 1 |
| Harvey, D | 1 |
| Rathbone, MP | 1 |
| Griesmaier, E | 1 |
| Stock, K | 1 |
| Medek, K | 1 |
| Stanika, RI | 1 |
| Obermair, GJ | 1 |
| Posod, A | 1 |
| Wegleiter, K | 1 |
| Urbanek, M | 1 |
| Kiechl-Kohlendorfer, U | 1 |
| Božić, K | 1 |
| Gebauer-Bukurov, K | 1 |
| Sakalaš, L | 1 |
| Divjak, I | 1 |
| Ješić, A | 1 |
| Strasser, K | 2 |
| Lueckemann, L | 1 |
| Kluever, V | 1 |
| Thavaneetharajah, S | 1 |
| Hoeber, D | 1 |
| Bendix, I | 1 |
| Fandrey, J | 1 |
| Bertsche, A | 1 |
| Felderhoff-Mueser, U | 1 |
| Bouchier, B | 1 |
| Demarquay, G | 1 |
| Guérin, C | 1 |
| André-Obadia, N | 1 |
| Gobert, F | 1 |
| Kuznetsova, LN | 1 |
| Datta, S | 1 |
| Hart, GK | 1 |
| Opdam, H | 1 |
| Gutteridge, G | 1 |
| Archer, J | 1 |
| Solanki, P | 1 |
| Prasad, D | 1 |
| Muthuraju, S | 1 |
| Sharma, AK | 1 |
| Singh, SB | 1 |
| Ilavzhagan, G | 1 |
| Kolisnikova, KN | 1 |
| Gudasheva, TA | 3 |
| Nazarova, GA | 1 |
| Antipov, TA | 1 |
| Voronina, TA | 2 |
| Seredenin, SB | 1 |
| Rekling, JC | 1 |
| Zarubina, IV | 3 |
| Shabanov, PD | 2 |
| Tai, KK | 1 |
| Truong, DD | 1 |
| Trollmann, R | 1 |
| Schneider, J | 1 |
| Keller, S | 1 |
| Wenzel, D | 1 |
| Rascher, W | 1 |
| Ogunshola, OO | 1 |
| Gassmann, M | 1 |
| Nikolova, M | 2 |
| Nikolov, R | 3 |
| Milanova, D | 1 |
| Fischer, HD | 7 |
| Schmidt, J | 7 |
| Wustmann, C | 7 |
| Koburova, K | 1 |
| Funk, KF | 1 |
| Lun, A | 1 |
| Pohle, R | 1 |
| Moller, R | 1 |
| Gross, J | 1 |
| Kopaladze, RA | 1 |
| Turova, NF | 1 |
| Ostrovskaia, RU | 4 |
| Trofimov, SS | 3 |
| Brenner, G | 1 |
| Sara, SJ | 1 |
| Ostrovskaya, RU | 1 |
| Hoffmann, W | 1 |
| Molodawkin, GM | 1 |
| Rostock, A | 1 |
| Dimov, S | 1 |
| Moyanova, S | 1 |
| Molodavkin, GM | 1 |
| Popova, RIa | 1 |
| Klink, F | 1 |
| von Klitzing, L | 1 |
| Grosspietzsch, R | 1 |
| Oberheuser, F | 1 |
| Demay, F | 1 |
| Bande, J | 1 |
| Saletu, B | 1 |
| Hitzenberger, G | 1 |
| Grünberger, J | 1 |
| Anderer, P | 1 |
| Zyhlarz, G | 1 |
| Linzmayer, L | 1 |
| Rameis, H | 1 |
| Larner, AJ | 1 |
| Heafield, MT | 1 |
| Chepkova, AN | 1 |
| Smoĺnikova, NI | 1 |
| Nagornev, SN | 1 |
| Sytnik, SI | 1 |
| Bobrovnitskiĭ, IP | 1 |
| Cherniakov, IN | 1 |
| Shishov, AA | 1 |
| Rauca, C | 1 |
| Jantze, H | 1 |
| Krug, M | 1 |
| Frucht, SJ | 1 |
| Polunin, BA | 1 |
| Tumanov, VP | 1 |
| Avrutskiĭ, MIa | 1 |
| Valame, SP | 1 |
| Naik, SR | 1 |
| Sheth, UK | 1 |
| Cremieux, C | 1 |
| Serratrice, G | 1 |
| Andreeva, NI | 1 |
| Golovina, SM | 1 |
| Parshin, VA | 1 |
| Mashkovskiĭ, MD | 1 |
| Akhundov, RA | 1 |
| Zagorevskiĭ, VA | 1 |
| Laszy, J | 1 |
| Sarkadi, A | 1 |
| Fahn, S | 1 |
| Rudolph, E | 2 |
| Murayama, M | 1 |
| Tkácová, R | 1 |
| Tomori, Z | 1 |
| Nistiarová, A | 1 |
| Golikov, AP | 1 |
| Karev, VA | 1 |
| Polumiskov, VIu | 1 |
| Konorev, LA | 1 |
| Berestov, AA | 1 |
| Schaffler, K | 2 |
| Klausnitzer, W | 1 |
| Petzold, D | 1 |
| Kunz, W | 1 |
| Grau, M | 1 |
| Montero, JL | 1 |
| Balasch, J | 1 |
| Gukasov, VM | 1 |
| Rasulov, MM | 1 |
| Efuni, SN | 1 |
| Kaplan, EIa | 1 |
| Smiriagina, VI | 1 |
| Gramatté, T | 1 |
| Tsorin, IB | 1 |
| Chichkanov, GG | 1 |
| Schiller, E | 1 |
5 trials available for piracetam and Anoxemia
| Article | Year |
|---|---|
[Reaction of the complement system in response to the nootropil correction of hypoxic state].
Topics: Adult; Altitude Sickness; Complement Activation; Complement System Proteins; Humans; Hypoxia; Male; | 2008 |
The effect of piracetam on volunteers in a low-pressure tank.
Topics: Adult; Attention; Double-Blind Method; Humans; Hypoxia; Piracetam; Pyrrolidinones | 1980 |
Double-blind, placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man.
Topics: Administration, Oral; Adult; Analysis of Variance; Blood Gas Analysis; Brain; Chromatography, High P | 1995 |
[Stimulation of reparative processes in myocardial infarction: comparative evaluation of the effects of piracetam and inosine].
Topics: Adult; Aged; Animals; Clinical Trials as Topic; Collagen; Drug Evaluation, Preclinical; Female; Free | 1988 |
Randomized placebo-controlled double-blind cross-over study on antihypoxidotic effects of piracetam using psychophysiological measures in healthy volunteers.
Topics: Adult; Double-Blind Method; Heart Rate; Humans; Hypoxia; Male; Piracetam; Psychomotor Performance; P | 1988 |
52 other studies available for piracetam and Anoxemia
| Article | Year |
|---|---|
Postanoxic myoclonus: two case presentations and review of medical management.
Topics: Aged; Anticonvulsants; Clonazepam; Drug Therapy, Combination; Humans; Hypoxia; Levetiracetam; Male; | 2014 |
Levetiracetam increases neonatal hypoxic-ischemic brain injury under normothermic, but not hypothermic conditions.
Topics: Animals; Apoptosis Inducing Factor; Caspase 3; Cell Count; Cell Death; Cells, Cultured; Cerebral Cor | 2014 |
Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report.
Topics: Accidents, Traffic; Anticonvulsants; Electroencephalography; Fracture Fixation, Internal; Humans; Hy | 2014 |
Dose-dependent effects of levetiracetam after hypoxia and hypothermia in the neonatal mouse brain.
Topics: Animals; Animals, Newborn; Anticonvulsants; Anxiety; Apoptosis; Behavior, Animal; Brain; Brain Injur | 2016 |
Marked EEG worsening following Levetiracetam overdose: How a pharmacological issue can confound coma prognosis.
Topics: Adult; Anticonvulsants; Coma; Drug Overdose; Electroencephalography; Female; Heart Arrest; Humans; H | 2017 |
Post-hypoxic myoclonic status: the prognosis is not always hopeless.
Topics: Aged; Anticonvulsants; Critical Care; Female; Heart Arrest; Humans; Hypoxia; Levetiracetam; Myoclonu | 2009 |
Preventive effect of piracetam and vinpocetine on hypoxia-reoxygenation induced injury in primary hippocampal culture.
Topics: Acetylcholinesterase; Animals; Antioxidants; Hippocampus; Hypoxia; In Vitro Techniques; L-Lactate De | 2011 |
[Similarity of cycloprolylglycine to piracetam in antihypoxic and neuroprotective effects].
Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Hypercapnia; Hypoxia; Mice; Mic | 2012 |
Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.
Topics: Acetates; Amines; Animals; Anticonvulsants; Carbamates; Carbamazepine; Cell Death; Cells, Cultured; | 2003 |
Drug correction of behavioral reactions and metabolic disorders in rats with craniocerebral trauma.
Topics: Animals; Antioxidants; Benzimidazoles; Body Weight; Brain; Brain Injuries; Carbon Tetrachloride Pois | 2003 |
[Significance of individual resistance to hypoxia for the correction of the brain trauma sequelae].
Topics: Acute Disease; Animals; Benzimidazoles; Brain; Brain Injuries; Disease Susceptibility; Hypoxia; Male | 2003 |
The significance of individual resistance to hypoxia for correction of the consequences of craniocerebral trauma.
Topics: Animals; Antioxidants; Behavior, Animal; Benzimidazoles; Body Temperature; Body Weight; Brain Edema; | 2005 |
Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsies, Myoc | 2007 |
HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Brain; Disease Models, Animal; Gene Ex | 2008 |
Anti-hypoxic effect of piracetam and its interaction with prostacyclin.
Topics: Animals; Atmospheric Pressure; Cinnarizine; Drug Synergism; Epoprostenol; Female; Hypoxia; Ischemia; | 1984 |
On some mechanisms of antihypoxic actions of nootropic drugs.
Topics: Animals; Corpus Striatum; Dopamine; Drug Interactions; Glycolates; Hypoxia; Meclofenoxate; Meglumine | 1984 |
Inhibition of phospholipase A2 in vitro by some anti-hypoxic drugs.
Topics: Arachidonic Acid; Arachidonic Acids; Humans; Hypoxia; In Vitro Techniques; Nicergoline; Papaverine; | 1984 |
Changes of dopamine metabolism by hypoxia and effect of nootropic drugs.
Topics: Animals; Brain; Caudate Nucleus; Diazepam; Dihydroergotoxine; Dopamine; Hypoxia; Meclofenoxate; Orot | 1984 |
Effects of piracetam on brain development in newborn rats exposed to hypoxia.
Topics: Animals; Animals, Newborn; Brain; Brain Chemistry; Corpus Striatum; Dopamine; Female; Hypoxia; Pirac | 1984 |
[Possible correction of the isoenzyme spectrum of lactate dehydrogenase in the developing rat brain in antenatal hypoxia].
Topics: Animals; Animals, Newborn; Brain; Cerebral Cortex; Hypoxia; Isoenzymes; L-Lactate Dehydrogenase; Med | 1984 |
[Nootropic properties of gamma-aminobutyric acid derivatives].
Topics: Amnesia; Amnesia, Retrograde; Animals; Avoidance Learning; Baclofen; Butyrates; Conditioning, Classi | 1984 |
[Effect of xanthinol nicotinate on brain metabolism in rats].
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Blood Pressure; Brain Chemistry; Glucose; Hypo | 1983 |
Memory retrieval deficits: alleviation by etiracetam, a nootropic drug.
Topics: Animals; Avoidance Learning; Electroshock; Food; Food Deprivation; Handling, Psychological; Hypoxia; | 1980 |
[Antihypoxic effect of tisochromide (16-244) in comparison with piracetam].
Topics: Animals; Brain; Electroencephalography; Heterocyclic Compounds; Hypoxia; Lactates; Mice; Oxathiins; | 1983 |
Effect of piracetam in some models of general and local depression of the cortical bioelectrical activity in cats.
Topics: Adenosine Monophosphate; Animals; Asphyxia; Cats; Cerebral Cortex; Depression, Chemical; Female; Hyp | 1983 |
[Neuropharmacological properties of piracetam derivatives].
Topics: Amnesia, Retrograde; Animals; Conditioning, Classical; Drug Evaluation, Preclinical; Electroencephal | 1982 |
[Mechanism of antihypoxic effect of depakine].
Topics: 4-Aminobutyrate Transaminase; Aminooxyacetic Acid; Animals; Brain; Dose-Response Relationship, Drug; | 1982 |
Alterations of the fetal EEG under the influence of labour, hypoxia and analgetics.
Topics: Analgesics; Brain; Electroencephalography; Female; Fetus; Humans; Hypoxia; Labor, Obstetric; Piracet | 1981 |
Post anoxic action myoclonus.
Topics: Clonazepam; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Hypoxia; Male; Middle Aged; Pi | 1993 |
[Damage to plastic properties of synaptic transmission in the rat hippocampus resulting from prenatal hypoxia, and their normalization by treatment with nootropic dipeptides].
Topics: Animals; Dipeptides; Female; Hippocampus; Hypoxia; Male; Neuronal Plasticity; Nootropic Agents; Pira | 1995 |
[Pharmacological correction of lipid peroxidation during hypoxia and possibility to enhance human resistance to high altitude by using preparations of the metabolic type of action].
Topics: Adaptation, Physiological; Adult; Altitude; Altitude Sickness; Anticholesteremic Agents; Antioxidant | 1996 |
Does fucose or piracetam modify the effect of hypoxia preconditioning against pentylenetetrazol-induced seizures?
Topics: Animals; Fucose; Hypoxia; Male; Neuroprotective Agents; Pentylenetetrazole; Piracetam; Rats; Rats, W | 2000 |
The clinical challenge of posthypoxic myoclonus.
Topics: 5-Hydroxytryptophan; Anticonvulsants; Clonazepam; Humans; Hypoxia; Levetiracetam; Myoclonus; Neuropr | 2002 |
[Effect of nootropil and contvykal on the structural changes in the central nervous system in hypoxic brain edema].
Topics: Animals; Aprotinin; Brain Edema; Central Nervous System; Drug Evaluation, Preclinical; Hypoxia; Pira | 1979 |
Effect of UCB-6215 on retention of CAR in rat under experimental seizure induced hypoxia.
Topics: Animals; Avoidance Learning; Electric Stimulation; Female; Hypoxia; Male; Memory; Piracetam; Rats | 1979 |
[Intention and post-anoxic action myoclonias. Amelioration by piracetam].
Topics: Female; Humans; Hypoxia; Middle Aged; Myoclonus; Piracetam; Pyrrolidinones | 1979 |
[Effects of antidepressive agents on tolerance of hypoxia and physical exercise].
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Carbazoles; Carbolines | 1991 |
[Nootropic activity of nicotinamide and its structural analogs].
Topics: Amnesia; Animals; Hypoxia; Male; Meclofenoxate; Mice; Niacinamide; Piracetam; Psychotropic Drugs; Py | 1990 |
Hypoxia-induced sleep disturbance in rats.
Topics: Animals; Dihydroergotoxine; Disease Models, Animal; Hypoxia; Male; Piracetam; Rats; Sleep Stages; Sl | 1990 |
Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.
Topics: Clonazepam; Drug Therapy, Combination; Estrogens, Conjugated (USP); Fasting; Female; Humans; Hydroxy | 1986 |
The antihypoxic effect of ethymisole: a comparison with other nootropic drugs.
Topics: Animals; Corpus Striatum; Dopamine; Etimizol; Hypoxia; Imidazoles; In Vitro Techniques; Kinetics; Ma | 1989 |
New aspects in mechanisms of antihypoxic piracetam action.
Topics: Animals; Brain; Corpus Striatum; Dopamine; Flunarizine; Hypoxia; In Vitro Techniques; Kinetics; Pira | 1989 |
DIPA (decompression-inducible platelet aggregation) and hemostasis: vascular occlusion and its prevention, in the web of the frog's foot.
Topics: Altitude Sickness; Animals; Decompression; Hemostasis; Hypoxia; Piracetam; Platelet Aggregation; Ran | 1989 |
Anti-hypoxic potency of cerebroprotective drugs studied in a model of acute reversible respiratory failure.
Topics: Animals; Brain Ischemia; Cats; Dihydroergotoxine; Disease Models, Animal; Electrocardiography; Hypox | 1989 |
Respiratory function of rat brain mitochondria after hypobaric hypoxia and piracetam treatment.
Topics: Animals; Brain; Hypoxia; Kinetics; Mitochondria; Oxygen Consumption; Piracetam; Pressure; Pyrrolidin | 1987 |
Effect of Piracetam on electrocorticogram and local cerebral glucose utilization in the rat.
Topics: Animals; Brain; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Electroencephalography; Energy Metaboli | 1987 |
[Characteristics of the antihypoxic action of piracetam].
Topics: Animals; Drug Evaluation, Preclinical; Erythrocytes; Hypoxia; Ischemia; Kidney; Kinetics; Lipid Pero | 1987 |
Protective and restitutive effects of antihypoxic drugs on posthypoxic dopamine release inhibition.
Topics: Amphetamine; Animals; Antioxidants; Chelating Agents; Corpus Striatum; Dopamine; Free Radicals; Hypo | 1986 |
[Pharmacodynamic bioequivalence of piracetam in hypoxic hypoxia].
Topics: Adult; Electroencephalography; Electrooculography; Humans; Hypoxia; Kinetics; Male; Piracetam; Pyrro | 1986 |
Effects of nootropic drugs on some behavioural and biochemical changes after early postnatal hypoxia in the rat.
Topics: Animals; Body Weight; Corpus Striatum; Deanol; Dopamine; Ethanolamines; Female; Hypoxia; In Vitro Te | 1986 |
[Effect of preparations with antihypoxic properties on ischemic damage to the myocardium].
Topics: Animals; Cats; Hypoxia; Male; Myocardial Infarction; Piracetam; Pyridoxine; Rats; Sodium Oxybate | 1986 |
[Proceedings: Electron microscopy and microinterferometry contributions on the functional mechanism of piracetam].
Topics: Animals; Brain; Female; Hypoxia; Male; Microscopy, Electron; Microscopy, Interference; Piracetam; Py | 1974 |